Technology

Tiina A. Lantto, Ph.D., and Max C. Moseley, MSc, Join The Acta Group’s Brussels and Manchester Offices

Published

on

The Acta Group (Acta®) is pleased to announce the expansion of our global scientific and regulatory capabilities with the appointments of Tiina A. Lantto, Ph.D., Regulatory Scientist and Toxicologist in our Brussels, Belgium, office, and Max L. Moseley, MSc, Regulatory Specialist in our Manchester, England, office.

WASHINGTON, Dec. 20, 2024 /PRNewswire-PRWeb/ — The Acta Group (Acta®) is pleased to announce the expansion of our global scientific and regulatory capabilities with the appointments of Tiina A. Lantto, Ph.D., Regulatory Scientist and Toxicologist in our Brussels, Belgium, office, and Max L. Moseley, MSc, Regulatory Specialist in our Manchester, England, office.

With offices in the United States, the UK, and the EU, Acta assists companies with complex registration and compliance issues under multiple regulatory schemes worldwide.

Dr. Tiina A. Lantto provides seasoned, sophisticated toxicology and regulatory guidance for worldwide chemical registration and compliance programs, with particular expertise in European chemical regulatory programs, including all aspects of the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation. Dr. Lantto’s two decades of experience as a toxicologist and regulatory scientist include serving as a regulatory science researcher and dossier evaluator with the European Chemicals Agency’s (ECHA) Classification and Prioritisation Unit and Evaluation Unit, as a toxicologist for a global fragrance and flavor company, as a consultant to international chemical and petrochemical companies, and as a researcher and instructor at the University of Helsinki. Dr. Lantto holds an MSc in Animal Biotechnology from the University of Eastern Finland and a Ph.D. in Pharmaceutical Biology from the University of Helsinki.

Max L. Moseley, MSc assists clients in the United Kingdom (UK), the European Union (EU), and worldwide with global chemical regulatory compliance while keeping a keen focus on attendant business impacts. Within the EU and UK REACH frameworks, he concentrates on the full spectrum of support services for co-registrants and lead registrants, including performing data gap assessments, authoring robust study summaries (RSS), completing quantitative structure-activity relationship (QSAR) assessments, and designing integrated testing strategies. Mr. Moseley offers clients particular expertise in green chemistry, sustainability, life cycle analysis, Greenhouse Gas Protocol Carbon Accounting standards, and meeting the objectives of the EU Chemicals Strategy for Sustainability (CSS). Mr. Moseley earned a BS in Chemistry and an MSc in Green Chemistry and Sustainable Industrial Technology, both from the University of York, England. He has spent the decade since as a trusted chemical regulatory and business consultant.

Acta is a scientific, business, and regulatory consulting firm staffed by experts who assist companies making or using chemicals to commercialize and sustain their products globally. With offices in the United States, the UK, and the EU, Acta assists companies with complex registration and compliance issues under multiple regulatory schemes worldwide. For more information, visit our website at http://www.actagroup.com. For timely updates and thoughtful analysis on developments under REACH and UK REACH, visit and subscribe to Acta’s REACHblog®, http://www.reachblog.com.

Acta is the consulting affiliate of Bergeson & Campbell, P.C. (B&C®), a Washington, D.C. law firm focusing on conventional, biobased, and nanoscale industrial, agricultural, and specialty chemical product approval and regulation, product defense, and associated business issues.

Media Contact

Heidi Lewis, The Acta Group, 202-557-3812, hlewis@actagroup.com, www.actagroup.com

View original content to download multimedia:https://www.prweb.com/releases/tiina-a-lantto-phd-and-max-c-moseley-msc-join-the-acta-groups-brussels-and-manchester-offices-302336956.html

SOURCE The Acta Group

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version